María D. López-Carmona

Author

Also Known As

José Antonio Hurtado Oliver, M. D. Lopez-Carmona, M. Dolores Lopez-Carmona, M.D. López-Carmona, Maria D. López-Carmona, Maria D. López‐Carmona, Maria Dolores Lopez-Carmona, Maria Dolores López-Carmona, María D. LÓPEZ-CARMONA, María D. López-Carmona

Publications

808

Citations

H-Index

Concepts

All Affiliations

Instituto de Salud Carlos III Instituto de Investigación Biomédica de Málaga Universidad de Málaga Hospital Regional Universitario de Málaga Centro de Investigación Biomédica en Red

About

María D. López-Carmona is an author at Instituto de Salud Carlos III specializing in public health, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	108
2	Public Health	5	5	108
3	Diabetes	4	4	87
4	Epidemiology	3	3	66
5	Nursing	1	1	32

María D. López-Carmona

Publications

522

Citations

H-Index

Page 1

	Year	Citations
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study Juan F. Alcalá‐Díaz, Laura Limia Pérez, Ricardo Gómez‐Huelgas, Nutrients	2021	113
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study Luis M. Pérez-Belmonte, José D. Torres‐Peña, María D. López-Carmona, BMC Medicine	2020	101
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain Enrique Rodilla, María D. López-Carmona, Xavier Cortés, Hypertension	2020	64
National trends in diabetes mellitus hospitalization in Spain 1997–2010: Analysis of over 5.4 millions of admissions Carmen M. Lara-Rojas, Luis M. Pérez‐Belmonte, María D. López-Carmona, European Journal of Internal Medicine HospitalizationDiabetes ManagementDiabetes Mellitus HospitalizationDiabetes EpidemiologyHealth Policy	2018	34
Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population Lidia Cobos-Palacios, M. Isabel Ruiz‐Moreno, Alberto Vilches-Pérez, PLoS ONE	2022	34
Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study Luis M. Pérez‐Belmonte, Julio Osuna‐Sánchez, Mercedes Millán‐Gómez, Annals of Medicine	2019	33
Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study) Luis M. Pérez‐Belmonte, Juan José Gómez‐Doblas, Mercedes Millán‐Gómez, Journal of Clinical Medicine HypertensionPharmacotherapyMetabolic SyndromeClinical EpidemiologyPublic Health	2018	32
Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure Luis M. Pérez‐Belmonte, Jaime Sanz‐Cánovas, Mercedes Millán‐Gómez, Journal of the American Geriatrics Society	2021	22
Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry José Manuel Ramos, María D. López-Carmona, Lidia Cobos-Palacios, Journal of Clinical Medicine Covid-19 EpidemiologyLogistic AnalysisCovid-19Hospital MedicineClinical Epidemiology	2022	21
CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes María D. López-Carmona, María del Carmen Plaza‐Seron, Antonio Vargas‐Candela, Diabetology & Metabolic Syndrome	2017	18

Page 1